Subtype
Hepatocellular Carcinoma
CI-CAN-00002853HCC · LIHCExplore in graph →
693 active trials13 approved drugs9 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002853HCC · LIHCExplore in graph →
Clinical trials
3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (357)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01891539 | Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma(DEBDOX) | unknown | — | 100 | International Group of Endovascular OncologyOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT03853928 | Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis | unknown | N/A | 280 | Austral University, ArgentinaOTHER | 0 | Feb 27, 2019 |
| clinicaltrials |
| NCT02232490 | Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L(Hepko-V5) | unknown | Phase 3 | 120 | Immunitor LLCINDUSTRY | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03851887 | The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 33 | Sun Yat-sen UniversityOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT03851939 | The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 65 | Sun Yat-sen UniversityOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT03734068 | Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC(LIFDOX) | unknown | — | 100 | International Group of Endovascular OncologyOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT03839550 | Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection | unknown | Phase 2 | 200 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03313596 | Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC | unknown | Phase 3 | 180 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 4, 2019 | clinicaltrials |
| NCT03614546 | Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma | unknown | N/A | 200 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03812783 | HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | unknown | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03807947 | Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma | unknown | N/A | 74 | Humanitas Clinical and Research CenterOTHER | 1 | Jan 17, 2019 | clinicaltrials |
| NCT03793322 | The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma | unknown | Phase 1 | 100 | Zhujiang HospitalOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT03793725 | A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC(HZ-T-PD1-APA) | unknown | Phase 2 | 30 | Yanqiao ZhangOTHER | 0 | Jan 4, 2019 | clinicaltrials |
| NCT03116945 | Novel Gallium Imaging in Hepatocellular Carcinoma | unknown | Phase 2 | 18 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03775395 | HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC | unknown | Phase 3 | 250 | Sun Yat-sen UniversityOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03730675 | Irradiation Stent Placement Plus TACE for HCC and PVTT | unknown | N/A | 308 | Zhongda HospitalOTHER | 1 | Dec 21, 2018 | clinicaltrials |
| NCT02759601 | Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)(CHR-2845) | unknown | Phase 1 / Phase 2 | 69 | Queen Mary University of LondonOTHER | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03722875 | SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery | unknown | N/A | 45 | Shanghai Zhongshan HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT03777475 | the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma | unknown | N/A | 350 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT02719782 | A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation | unknown | Phase 1 | 10 | Lion TCR Pte. Ltd.INDUSTRY | 1 | Nov 16, 2018 | clinicaltrials |
| NCT03732547 | Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 60 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 16, 2018 | clinicaltrials |
| NCT03739164 | Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)(TAMLAPS) | unknown | — | 10 | Florida Hospital Tampa Bay DivisionOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT03722628 | The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC | unknown | — | 200 | Assiut UniversityOTHER | 0 | Oct 29, 2018 | clinicaltrials |
| NCT03668158 | Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma | unknown | — | 500 | Zhejiang UniversityOTHER | 0 | Oct 24, 2018 | clinicaltrials |
| NCT03708705 | Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study | unknown | — | 500 | Zhejiang UniversityOTHER | 0 | Oct 19, 2018 | clinicaltrials |
| NCT02743065 | HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China(SUPER-China) | unknown | — | 100 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT03672305 | Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC | unknown | Early Phase 1 | 50 | The Second Hospital of Nanjing Medical UniversityOTHER | 0 | Sep 18, 2018 | clinicaltrials |
| NCT03005756 | Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients(NGR) | unknown | N/A | 20 | Asan Medical CenterOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03652896 | Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma | unknown | N/A | 60 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT02293850 | Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 18 | Oncolys BioPharma IncINDUSTRY | 2 | Aug 20, 2018 | clinicaltrials |
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 3 | 252 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03609151 | Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03609268 | Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03594929 | Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery | unknown | N/A | 50 | Singapore General HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02678806 | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion(RHCC:BCLC-A) | unknown | N/A | 620 | Guangxi Medical UniversityOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03129685 | Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma(NRU) | unknown | N/A | 12 | The National Ribat UniversityOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT03551444 | Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial(CAUTIOUS) | unknown | Phase 3 | 80 | Ain Shams UniversityOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | unknown | Phase 3 | 296 | Fudan UniversityOTHER | 1 | Jun 1, 2018 | clinicaltrials |
| NCT01834963 | P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. | unknown | Phase 2 | 66 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | May 18, 2018 | clinicaltrials |
| NCT03520257 | The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus | unknown | Phase 2 | 50 | Guangxi Medical UniversityOTHER | 0 | May 9, 2018 | clinicaltrials |
| NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | unknown | Phase 4 | 130 | Korea UniversityOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03516448 | Expanding Phase III Study of Tyroserleutide for Injection | unknown | Phase 3 | 352 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 0 | May 4, 2018 | clinicaltrials |
| NCT03515369 | Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 4 | 459 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | May 3, 2018 | clinicaltrials |
| NCT03285867 | Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma | unknown | — | 200 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT03511703 | The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients | unknown | Phase 2 | 40 | Guangxi Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT01135056 | Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)(SIRveNIB) | unknown | Phase 3 | 360 | Singapore General HospitalOTHER | 12 | Apr 24, 2018 | clinicaltrials |
| NCT03132740 | Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma | unknown | — | 2,000 | Zhujiang HospitalOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT03191123 | Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor | unknown | N/A | 100 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 13, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2019source: clinicaltrials